Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PEDIATRIC ADVIL

IBUPROFEN

Standard Dose
100MG/2.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PEDIATRIC ADVIL is listed in Drugs@FDA under application 020812 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength SUSPENSION/DROPS;ORAL - 100MG/2.5ML Sponsor HALEON US HOLDINGS Submission history Latest submission status date: 2017-07-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview PEDIATRIC ADVIL is listed in Drugs@FDA under application 020812 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength SUSPENSION/DROPS;ORAL - 100MG/2.5ML Sponsor HALEON US HOLDINGS Submission history Latest submission status date: 2017-07-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.